These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 22511072)
1. Quantification of PKC family genes in sporadic breast cancer by qRT-PCR: evidence that PKCι/λ overexpression is an independent prognostic factor. Awadelkarim KD; Callens C; Rossé C; Susini A; Vacher S; Rouleau E; Lidereau R; Bièche I Int J Cancer; 2012 Dec; 131(12):2852-62. PubMed ID: 22511072 [TBL] [Abstract][Full Text] [Related]
2. Integrative genomic analysis of protein kinase C (PKC) family identifies PKCiota as a biomarker and potential oncogene in ovarian carcinoma. Zhang L; Huang J; Yang N; Liang S; Barchetti A; Giannakakis A; Cadungog MG; O'Brien-Jenkins A; Massobrio M; Roby KF; Katsaros D; Gimotty P; Butzow R; Weber BL; Coukos G Cancer Res; 2006 May; 66(9):4627-35. PubMed ID: 16651413 [TBL] [Abstract][Full Text] [Related]
3. Expression of protein kinase C isoforms in cultured human Tenon's capsule fibroblast cells. Ma P; Gao Q; Wang Z; Yu K Mol Med Rep; 2015 Oct; 12(4):6025-30. PubMed ID: 26260704 [TBL] [Abstract][Full Text] [Related]
4. Expression of protein kinase C isoforms in cultured human retinal pigment epithelial cells. Yu K; Ma P; Ge J; Willey CD; Yang P; Wang Z; Gao Q Graefes Arch Clin Exp Ophthalmol; 2007 Jul; 245(7):993-9. PubMed ID: 17124607 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value of ERBB family mRNA expression in breast carcinomas. Bièche I; Onody P; Tozlu S; Driouch K; Vidaud M; Lidereau R Int J Cancer; 2003 Sep; 106(5):758-65. PubMed ID: 12866037 [TBL] [Abstract][Full Text] [Related]
6. Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas. Girault I; Tozlu S; Lidereau R; Bièche I Clin Cancer Res; 2003 Oct; 9(12):4415-22. PubMed ID: 14555514 [TBL] [Abstract][Full Text] [Related]
7. The protein kinase C (PKC) family of proteins in cytokine signaling in hematopoiesis. Redig AJ; Platanias LC J Interferon Cytokine Res; 2007 Aug; 27(8):623-36. PubMed ID: 17784814 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of protein kinase C alpha mRNA in human hepatocellular carcinoma: a potential marker of disease prognosis. Wu TT; Hsieh YH; Wu CC; Hsieh YS; Huang CY; Liu JY Clin Chim Acta; 2007 Jul; 382(1-2):54-8. PubMed ID: 17459358 [TBL] [Abstract][Full Text] [Related]
9. Quantitation of hTERT gene expression in sporadic breast tumors with a real-time reverse transcription-polymerase chain reaction assay. Bièche I; Noguès C; Paradis V; Olivi M; Bedossa P; Lidereau R; Vidaud M Clin Cancer Res; 2000 Feb; 6(2):452-9. PubMed ID: 10690523 [TBL] [Abstract][Full Text] [Related]
10. Heregulin-induced apoptosis is mediated by down-regulation of Bcl-2 and activation of caspase-7 and is potentiated by impairment of protein kinase C alpha activity. Le XF; Marcelli M; McWatters A; Nan B; Mills GB; O'Brian CA; Bast RC Oncogene; 2001 Dec; 20(57):8258-69. PubMed ID: 11781840 [TBL] [Abstract][Full Text] [Related]
11. [Study of the correlation between HER-2 gene and lymphangiogenesis and their prognostic significance in human breast cancer]. Zhang GH; Yang WT; Zhou XY; Zeng Y; Lu HF; Shi DR Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):155-60. PubMed ID: 17425844 [TBL] [Abstract][Full Text] [Related]
12. Loss of heterozygosity at 13q14 correlates with RB1 gene underexpression in human breast cancer. Bièche I; Lidereau R Mol Carcinog; 2000 Nov; 29(3):151-8. PubMed ID: 11108660 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of maspin mRNA expression in ER alpha-positive postmenopausal breast carcinomas. Bièche I; Girault I; Sabourin JC; Tozlu S; Driouch K; Vidaud M; Lidereau R Br J Cancer; 2003 Mar; 88(6):863-70. PubMed ID: 12644823 [TBL] [Abstract][Full Text] [Related]
14. Prognostic Significance of VEGFC and VEGFR1 mRNA Expression According to HER2 Status in Breast Cancer: A Study of Primary Tumors from Patients with High-risk Early Breast Cancer Participating in a Randomized Hellenic Cooperative Oncology Group Trial. Linardou H; Kalogeras KT; Kronenwett R; Alexopoulou Z; Wirtz RM; Zagouri F; Scopa CD; Gogas H; Petraki K; Christodoulou C; Pavlakis K; Koutras AK; Samantas E; Patsea H; Pectasides D; Bafaloukos D; Fountzilas G Anticancer Res; 2015 Jul; 35(7):4023-36. PubMed ID: 26124351 [TBL] [Abstract][Full Text] [Related]
15. Protein kinase C isoform expression in ovarian carcinoma correlates with indicators of poor prognosis. Weichert W; Gekeler V; Denkert C; Dietel M; Hauptmann S Int J Oncol; 2003 Sep; 23(3):633-9. PubMed ID: 12888898 [TBL] [Abstract][Full Text] [Related]
16. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level. Xu C; Yamamoto-Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Okumura Y; Yamaguchi L; Fujiki Y; Iwase H Breast Cancer; 2014 Jul; 21(4):482-90. PubMed ID: 22968628 [TBL] [Abstract][Full Text] [Related]
17. Clinical significance of atypical protein kinase C (PKCι and PKCζ) and its relationship with yes-associated protein in lung adenocarcinoma. Kim KH; Chung C; Kim JM; Lee D; Cho SY; Lee TH; Cho HJ; Yeo MK BMC Cancer; 2019 Aug; 19(1):804. PubMed ID: 31412817 [TBL] [Abstract][Full Text] [Related]
18. Atypical protein kinase C iota is an oncogene in human non-small cell lung cancer. Regala RP; Weems C; Jamieson L; Khoor A; Edell ES; Lohse CM; Fields AP Cancer Res; 2005 Oct; 65(19):8905-11. PubMed ID: 16204062 [TBL] [Abstract][Full Text] [Related]
19. The role of aromatase and 17-beta-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer. Salhab M; Reed MJ; Al Sarakbi W; Jiang WG; Mokbel K Breast Cancer Res Treat; 2006 Sep; 99(2):155-62. PubMed ID: 16541304 [TBL] [Abstract][Full Text] [Related]
20. Targeting the oncogenic protein kinase Ciota signalling pathway for the treatment of cancer. Fields AP; Frederick LA; Regala RP Biochem Soc Trans; 2007 Nov; 35(Pt 5):996-1000. PubMed ID: 17956262 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]